How Will You Manage Particulates In Your Parenteral Drug Product?
Source: West Pharmaceutical Services, Inc.
The biologics R&D pipeline is getting more competitive and the growing regulatory complexity, especially around particulate control, makes the potential to get it wrong significant.
Learn more about the three main types of particulates, some of which may not be evident until storage of the drug product: inherent, intrinsic, and extrinsic.
Explore NovaPure® Components: Quality Packaging Begins By Design.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
Subscribe to Biosimilar Development
X
Subscribe to Biosimilar Development
This website uses cookies to ensure you get the best experience on our website. Learn more